Product Reports Resources Pricing Login Book a demo

Sanofi

Health · Paris, France · Founded 1973 · IPO 2002

A global integrated healthcare leader discovers, develops and distributes therapeutic solutions MoreLess

Sanofi is a global healthcare company dedicated to providing innovative treatments and life-saving vaccines to millions of people worldwide. Operating in the pharmaceutical and biotechnology sectors, Sanofi focuses on research and development (R&D) to address unmet medical needs in areas such as immunology, oncology, rare diseases, and vaccines. The company serves a diverse range of clients, including patients, healthcare professionals, and governments, by offering a broad portfolio of prescription medicines, over-the-counter products, and vaccines.

Sanofi's business model revolves around extensive R&D efforts, strategic partnerships, and a robust pipeline of new products. The company invests heavily in scientific innovation to develop breakthrough therapies and improve existing treatments. Revenue is generated through the sale of pharmaceutical products and vaccines, as well as through collaborations and licensing agreements with other healthcare entities.

Sanofi operates in a highly competitive market, with a strong presence in both developed and emerging markets. The company leverages its global reach and expertise to navigate regulatory environments and deliver its products to those in need. By focusing on patient-centric solutions and maintaining a commitment to quality and safety, Sanofi aims to improve health outcomes and enhance the quality of life for people around the world.

Keywords: healthcare, pharmaceuticals, vaccines, R&D, immunology, oncology, rare diseases, biotechnology, global reach, patient-centric.

Valuation $100B
Revenue $52B
EBITDA $16B

Talent graph

Sanofi's talent

Book a demo to see the people
Team profiled 92 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on Sanofi's cap table

Sourced from Dealroom's funding history.

Seed 3 investors entered at this stage
HHS Administration for Strategic Preparedness and Response
European Commission
Germany
Series B+ 7 investors entered at this stage
Elf
Evotec
Blackstone
Deutsche Bank
ING Group
JP Morgan
Santander CIB

Global footprint

Where Sanofi has talent and traffic

Workforce by country
🇫🇷 France · Paris HQ
Book a demo for the full country breakdown

Market sentiment

What the market is saying about Sanofi

An AI-synthesized read of the highest-engagement posts about Sanofi on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sanofi on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.